Hcw Biologics INC. (HCWB) SEC Filings — 2024
19 SEC filings for Hcw Biologics INC. (HCWB) in 2024.
Filings
- HCW Biologics Faces Delisting Concerns — 8-K · Dec 23, 2024
- Hing C. Wong Amends HCW Biologics Stake Filing — SC 13D/A · Nov 22, 2024
- HCW Biologics Files 8-K: Material Agreement & Equity Sales — 8-K · Nov 20, 2024
- HCW Biologics Inc. Enters Material Definitive Agreement — 8-K · Nov 18, 2024
- HCW Biologics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- HCW Biologics Changes Independent Auditor — 8-K · Sep 20, 2024
- HCW Biologics Files 8-K/A Amendment — 8-K/A · Aug 23, 2024
- HCW Biologics Files Q2 2024 10-Q, Appoints New EVP — 10-Q · Aug 14, 2024
- HCW Biologics Faces Delisting Concerns — 8-K · Aug 12, 2024
- HCW Biologics Enters Material Definitive Agreement — 8-K · Jul 18, 2024
- HCW Biologics Faces Delisting Notice — 8-K · Jun 20, 2024
- HCW Biologics Files 8-K on Shareholder Votes — 8-K · Jun 17, 2024
- HCW Biologics Inc. Files 10-K/A Amendment — 10-K/A · May 15, 2024
- HCW Biologics Restates Financials — 8-K · May 3, 2024
- HCW Biologics Raises $2.4M in Direct Offering — 8-K · May 1, 2024
- HCW Biologics Inc. Announces 2024 Annual Meeting of Stockholders on June 14 — DEF 14A · Apr 26, 2024
- HCW Biologics Inc. Files 2023 Annual Report (10-K) — 10-K · Apr 1, 2024
- HCW Biologics Sells Unregistered Equity Securities — 8-K · Feb 22, 2024
- HCW Biologics Terminates Material Definitive Agreement — 8-K · Jan 12, 2024